Aisling Capital Management’s Syndax Pharmaceuticals SNDX Stock Holding History

Aisling Capital Management’s Portfolio SNDX Stock Details SNDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$28.8M	Hold	1,316,806	–	–	6.1%	3
2026 Q1	$30.8M	Hold	1,316,806	–	–	6.46%	2
2025 Q4	$27.7M	Hold	1,316,806	–	–	5.78%	2
2025 Q3	$20.3M	Hold	1,316,806	–	–	4.44%	3
2025 Q2	$12.3M	Buy	1,316,806 +291,806	+28%	+$3.21M	3.43%	3
2025 Q1	$12.6M	Hold	1,025,000	–	–	4.36%	3
2024 Q4	$13.6M	Hold	1,025,000	–	–	4.81%	3
2024 Q3	$19.7M	Hold	1,025,000	–	–	7.56%	3
2024 Q2	$21M	Hold	1,025,000	–	–	9.11%	2
2024 Q1	$24.4M	Hold	1,025,000	–	–	8.26%	2
2023 Q4	$22.2M	Hold	1,025,000	–	–	6.61%	3
2023 Q3	$14.9M	Hold	1,025,000	–	–	6.13%	3
2023 Q2	$21.5M	Hold	1,025,000	–	–	10.51%	3
2023 Q1	$21.6M	Hold	1,025,000	–	–	10.42%	4
2022 Q4	$26.1M	Hold	1,025,000	–	–	17.22%	3
2022 Q3	$24.6M	Hold	1,025,000	–	–	16.36%	2
2022 Q2	$19.7M	Hold	1,025,000	–	–	14.07%	2
2022 Q1	$17.8M	Hold	1,025,000	–	–	9.61%	3
2021 Q4	$22.4M	Hold	1,025,000	–	–	7.92%	3
2021 Q3	$19.6M	Hold	1,025,000	–	–	3.91%	6
2021 Q2	$17.6M	Hold	1,025,000	–	–	2.82%	6
2021 Q1	$22.9M	Hold	1,025,000	–	–	4.13%	4
2020 Q4	$22.8M	Hold	1,025,000	–	–	3.91%	5
2020 Q3	$15.1M	Hold	1,025,000	–	–	4.83%	4
2020 Q2	$15.2M	Buy	1,025,000 +150,000	+17%	+$2.28M	5.8%	5
2020 Q1	$9.6M	Buy	+875,000	New	+$8.21M	4.18%	4

Other funds holding SNDX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

Aisling Capital Management's SNDX Position: Q2 2026 in Review

Aisling Capital Management held its Syndax Pharmaceuticals (SNDX) position steady in Q2 2026 at 1,316,806 shares worth $28.8M. The position accounts for 6.1% of the portfolio, ranked #3.

Aisling Capital Management first reported a position in SNDX in Q1 2020 and has held it in 26 quarters since. The position peaked at $30.8M in Q1 2026. 242 funds tracked by Wall St. Rank hold SNDX as of Q2 2026.

Aisling Capital Management held 1,316,806 shares of Syndax Pharmaceuticals worth $28.8M as of Q2 2026.
Aisling Capital Management left its Syndax Pharmaceuticals share count unchanged in Q2 2026.
Syndax Pharmaceuticals made up 6.1% of Aisling Capital Management's portfolio in Q2 2026, its #3 holding.
Aisling Capital Management first reported a position in Syndax Pharmaceuticals in Q1 2020 and has held it in 26 quarters since.
Aisling Capital Management's Syndax Pharmaceuticals position peaked at $30.8M in Q1 2026.
242 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q2 2026.

Based on Aisling Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.